Stempoint Capital »

Surrozen shares owned by Stempoint Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.6M 144k 10.95

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Merus N V (MRUS)
Arcellx Common Stock (ACLX)
Amicus Therapeutics (FOLD)
Immunocore Hldgs Ads (IMCR)
Applied Therapeutics (APLT)
Merck & Co (MRK)
GSK Sponsored Adr (GSK)
Autolus Therapeutics Spon Ads (AUTL)
Cabaletta Bio (CABA)
Kalvista Pharmaceuticals (KALV)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Surrozen

RA Capital Management
Alyeska Investment Group
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Euclidean Capital
Stonepine Capital Management
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Geode Capital Management
Renaissance Technologies
BlackRock

View all funds holding Surrozen